
Results 1 - 20 of 564 in Schizophrenia
Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout...
... (KO) mice display hyper-locomotion in response to D-amphetamine which is considered a positive symptom of schizophrenia in animal models. Postmortem studies identified PKCI/HINT1 as a candidate molecule for schizophrenia and bipolar disorder. We ... Comment?
Thinking Matters: Psychotherapy, Dreaming, and Psychoanalysis
It's nonsense that dreams are meaningless. Okay folks, here's the problem. When it comes to insight, listening with the third ear , and especially to the personal tradition one has of practicing introspection, of practicing the sequence-analysis of the stream of consciousness, the psychoanalysts who have been at it for more than a 100 years are ... Comment?
Anti-psychotic drugs linked to deaths
w/Photo
... 1,800 deaths are linked to the drugs. The anti-psychotic drugs in question were originally developed to treat schizophrenia but over the past 30 years they have been increasingly used to subdue disturbed or violent dementia patients. According to ... Comment?
Uneccessary deaths linked to psychotic drugs
... reports from London. PHILIP WILLIAMS: The anti-psychotic drugs in question were originally developed to treat schizophrenia but over the past 30 years they've been increasingly used to subdue disturbed or violent dementia patients. The report says ... Comment?
... four-year investigation of the Indianapolis drug company. Shurtleff says Zyprexa is approved for treatment of schizophrenia and bipolar disorder . But he says Lilly's sales force illegally promoted Zyprexa for uses not approved by the Food and Drug ... Comment?
Lilly to pay $24M settlement to Utah over Zyprexa claims
... four-year investigation of the Indianapolis drug maker. Shurtleff said Zyprexa is approved for treatment of schizophrenia and bipolar disorder. But he said Lilly's sales force illegally promoted Zyprexa for uses not approved by the Food and Drug ... Comment?
Canadians' pill-popping packs on the extra pounds, experts warn
... "atypical antipsychotics," have been "tremendous in terms of bringing back the functionality of people with schizophrenia, bipolar disorders and depression." But Harvard University psychologist Paula Caplan warns of a vicious cycle, in which ... Comment?
Utah gets $24M in Zyprexa settlement
... drug Zyprexa, Utah Attorney General Mark Shurtleff said today. Zyprexa is approved for the treatment of schizophrenia and certain types of bipolar disorder, Shurtleff said. But he said the company's sales force illegally promoted Zyprexa for uses ... Comment?
Children 'highly vulnerable' to antipsychotic drugs
... Institute for Medical Research in New York, studied 272 children and teens aged 4 to 19 with bipolar disorder, schizophrenia and disruptive or aggressive behavior spectrum disorders. After roughly 11 weeks, those who took Zyprexa gained an average ... Comment?
National And International Report / Utah settles with Eli Lilly over Zyprexa marketing for $24M
... investigation of the drug maker based in Indianapolis. Shurtleff said Zyprexa is approved for treatment of schizophrenia and bipolar disorder. But he said Lilly's sales force illegally promoted Zyprexa for uses not approved by the Food and Drug ... Comment?
AG says Utah agrees to $24M Zyprexa settlement
... drug Zyprexa, Utah Attorney General Mark Shurtleff said Wednesday. Zyprexa is approved for the treatment of schizophrenia and certain types of bipolar disorder, Shurtleff said. But he said the company's sales force illegally promoted Zyprexa for ... Comment?
Utah snags $24M in drug settlement
... announced Wednesday. While the Food and Drug Administration approved the drug's use for the treatment of schizophrenia and bipolar disorders, Eli Lilly's long-term-care sales force, in 1999, encouraged doctors to prescribe it for dementia, ... Comment?
Ely Lilly In $24 Million Zyprexa Settlement With Utah
w/Photo
... drug Zyprexa, Utah Attorney General Mark Shurtleff said Wednesday. Zyprexa is approved for the treatment of schizophrenia and certain types of bipolar disorder, Shurtleff said. But he said the company's sales force illegally promoted Zyprexa for ... Comment?
Lilly to pay Utah $24 million to settle Zyprexa suit
... the state's Medicaid program on Zyprexa prescriptions. The state claimed Lilly promoted Zyprexa, approved for schizophrenia and bipolar disorder, for unapproved purposes, Bloomberg said. The settlement is the latest in a string of legal challenges ... Comment?
Utah AG Says State Getting $24M in Settlement
w/Photo
... association with significant weight gain and obesity. Shurtleff says Zyprexa is approved for the treatment of schizophrenia and certain types of bipolar disorder. But he says the company's sales force illegally promoted Zyprexa for uses not approved ... Comment?
Virtual Reality Treatment for PTSD.
... providing the ideal setting for effective rehabilitation. If you're currently seeking treatment for schizophrenia, drug addiction or any combination of mental illness and substance issues for yourself or someone you love, we encourage you to explore ... Comment?
Experts seek to learn from madness
... that they lack insight into their condition. Based on evidence in Europe, where people with a diagnosis of schizophrenia are reclaiming their lives by the tens of thousands, Ms. Hornstein presents a new model for treating those who hear voices and ... Comment?
Roche reports positive Phase II results with potential first-in-class ...
... that the compound improved both the negative symptoms and the personal and social functioning of patients with schizophrenia reaching statistical significance on primary and secondary endpoints.There are currently no effective therapies available ... Comment?
AstraZeneca - Seroquel: Furious Seasons - More on Dr Michel Reinstein
... with AZ because it wouldn't fund a study of Seroquel at, drum roll, 1,600 mgs. a day for people diagnosed with schizophrenia. Seriously. That's roughly twice of the high end that you ever see anyone on with this drug, and you hope no one is ever on ... Comment?
Alkermes Moves to Loss but Beats
... based on Risperdal Consta sales of $352.6 million, as against $8.4 million, on sales of $343.1 million of the schizophrenia drug for the comparable period in 2008. Net collaborative profit for Vivitrol, for the treatment of alcohol dependence, came ... Comment?